News
Overview of Short Bowel Syndrome MarketThe Global Short Bowel Syndrome Market is valued at USD 1.76 Billion in 2024 and is projected to attain a value of USD 3.66 Billion by 2035 at a CAGR of 6.91% ...
An instructor of medicine is concerned cannabis hyperemesis syndrome (CHS) is being diagnosed too often without a proper ...
Pervasive stigma around cannabis use is leading some ER doctors to overdiagnose a rare marijuana-related syndrome.
After a season of regulatory upheaval, obesity and rare genetic diseases will likely remain major themes for biopharma in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results